Company / Interest Expense
CAPRICOR THERAPEUTICS, INC. Interest Expense History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-
FY2018
5-year range
-
FY2016-FY2018
Trend
-100.0%
vs FY2017
Sector context
#42 of 46
Health Care
What the data says
Improved from $344,665 to $0 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 46
▼
Key checks
Key Insights
- In FY2018, interest expense decreased 100.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0 | -100.0% |
| FY2017 | $398.8K | +15.7% |
| FY2016 | $344.7K | +38.6% |
As of FY2018 · SEC 10-K · Updated Jul 4, 2026